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Family carers of individuals living with Huntington’s disease (HD) manage a distinct
and unique series of difficulties arising from the complex nature of HD. This paper
presents the validation of the definitive measure of quality of life (QoL) for this group.
The Huntington’s Disease Quality of Life Battery for Carers (HDQoL-C) was expanded
(n = 47) and then administered to an international sample of 1716 partners and family
carers from 13 countries. In terms of the psychometric properties of the tool, exploratory
analysis of half of the sample demonstrated good internal consistency and reliability.
Some items on the full version did not meet psychometric thresholds and a short version
(HDQoL-Cs) (n = 23) was developed based on more stringent criteria. This was achieved
using standard psychometric item reduction techniques to both increase reliability and
reduce the burden of carers completing the scale. Confirmatory factor analysis of the
model structure showed a good fit for all factors and indicated that the HDQoL-C
and HDQoL-Cs are psychometrically robust measures of QoL. We found that carers
who lived with and looked after their spouse/partner had reduced sense of coping,
hope for the future, and overall QoL. Carers with children who were at risk carried
the gene or were symptomatic also had poorer QoL outcomes. Findings indicated the
HDQoL-C and HDQoL-Cs are valid in multiple languages and across varied cultures
as measures of self-reported QoL in family carers of individual’s living with HD. These
psychometrically validated tools can aid and guide the implementation of therapeutic
interventions to improve life quality in this population and research into international
and cross-cultural carer experiences. The HDQoL-Cs is recommended as the definitive
international measure of HD carer QoL.
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INTRODUCTION
Huntington’s disease (HD) is a chronic and degenerative disorder
causing movement abnormalities, cognitive deterioration, and
affective disturbances (Bates et al., 2002; Quarrell, 2008; Ho
et al., 2011). It is a genetic condition inherited as an autosomal
dominant trait (Hartelius et al., 2010). There is currently no
cure for HD, with treatments being symptomatic, palliative, or
experimental in nature (Imarisio et al., 2008). It is often the
immediate family that assume the responsibility of care for the
individual living with HD (Aubeeluck et al., 2012). The hereditary
nature of HD appears to place additional burden on patients
(Ho et al., 2019) placing additional strain and a duty of care
onto carers (Williams et al., 2000) impacting on their quality of
life (QoL) (Aubeeluck et al., 2012). In HD the carer journey is
one that is decades long, with implications for the partner or
eventual carer early on in the piece, given the impact of genetic
testing for HD and also behavioral and cognitive changes which
may even precede overt motor symptomatology and diagnosis.
Partners will often have the added burden of knowing the risk
for their offspring. Caring for an individual living with HD and
raising children who have a 50% risk of eventually developing
HD is emotionally challenging and may lead to increased worry
compared to other, non-genetic diseases (Ho et al., 2019). In
particular, HD carers report burden, isolation, financial pressures
(Semple, 1995), difficulty in coping (Carreon et al., 2018), the
management of cognitive/behavioral symptoms (Simpson et al.,
2016), and emotional distress (Williams et al., 2009) as associated
with their caregiving role.
There has been a steady growth in work that explores the
impact of HD on the QoL of family carers. The existing literature
would argue that health and life quality are reduced in this carer
group (e.g., Kessler, 1993; Ready et al., 2008; Williams et al., 2009;
Hartelius et al., 2010; Skirton et al., 2010; van Walsem et al.,
2017). Mestre et al. (2018) argue that health-related quality of
life (HRQoL) is an important outcome measure that can form
part of the core clinical assessment of individual’s living with HD
and their carers. They rated the Huntington’s Disease Quality
of Life Battery for carers (HDQoL-C; Aubeeluck and Buchanan,
2005, 2007) as a “suggested” tool for use with family carers of
such individuals but not as a “recommended” measure and called
for further validation to be completed across the measures they
considered. The present paper addresses this issue.
Aubeeluck et al. (2013) further explored the properties of the
HDQoL-C in French and Italian translations. This study found
additional evidence for the reliability and validity of the scale in a
cross-cultural sample and also showed a differing factor structure
from the Aubeeluck and Buchanan (2007) study. Thus indicating
the need for further international validation of QoL measures for
HD carers to devise a generalizable cross-cultural measure.
The Enroll-HD clinical research database presented an
opportunity to revalidate the HDQoL-C (Aubeeluck and
Buchanan, 2007) with an international sample of partners and
family carers to allow for the development of a truly international
clinical tool for the measurement of QoL in HD carers. As this
expanded measure is widely used but has not previously been
subjected to psychometric scrutiny it was important to examine
the reliability of the expanded HDQoL-C. To this end, the
present study assessed the psychometric components of an
expanded version of the HDQoL-C (developed in collaboration
with the European HD QoL Working Group) and explored
self-reported QoL in family carers of individuals living with
HD to support the goals of screening and severity testing in
the HD carers population using principal axis factoring (PAF).
The psychometric properties of the revalidated HDQoL-C were
then scrutinized with the goal of refining the measure based
on psychometric item reduction procedures. The paper then
examines the case for the resulting short-form of the scale
which would have obvious benefits for carers if equivalent
or increased reliability were to be demonstrated. The factor
structures were finally tested with confirmatory factor analysis
(CFA). Demographic and situational effects on QoL were also
explored to test the validity of the tool. Thus, the aims of this
study were to (a) evaluate the psychometric properties of the
expanded version of the HDQoL-C and (b) identify whether a
more psychometrically robust, shorter version of the scale could
be derived for future use in clinical practice and research.
MATERIALS AND METHODS
Participants
Enroll-HD is a global clinical research platform designed to
facilitate clinical research in HD. Core data sets are collected
annually on all research participants as part of this multi-center
longitudinal observational study of HD. Carers who participate
in Enroll-HD complete the HDQoL-C during annual study
visits as part of their participation. This project is ongoing but
at the time of data retrieval, a total of 1716 partners/carers
were participating in this multi-center international study. The
mean age of participants was 52.8 (SD = 13.1), 59.5% of
the sample were female and 40.4% were male, 0.1% did not
respond to the question. They were recruited as part of the
Enroll-HD observational study of HD, where partners/carers also
provide information. The Enroll-HD study collected data from
Argentina, Australia, Canada, Denmark, France, Germany, Italy,
New Zealand, Netherlands, Poland, Spain, United Kingdom, and
the United States.
Data are monitored for quality and accuracy using a risk-
based monitoring approach. All sites are required to obtain and
maintain local Ethics Committee approvals. Enroll-HD recruits
through specialty clinics involved in HD who have ethical
approval for this study11. Oversight of the local approvals is
from the Enroll ethics working group2 who ensure that the
Enroll project achieves full compliance with national and regional
Ethics, Scientific Appraisal for data release, and Data Transfer
regulation legislation and best practice. The data included in
the manuscript were obtained as part of the Enroll project,
and Enroll-HD have approved the data to be used in this
paper (reference code SPS017). All participants provided written
1https://www.enroll-hd.org/participate/clinic-locations/
2https://www.enroll-hd.org/ethics/
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informed consent to take part and are free to withdraw at any
point without any implications on care.
Questionnaire
The HDQoL-C was developed using data gathered from three
preliminary qualitative studies (Aubeeluck, 2005; Aubeeluck
and Buchanan, 2006). Study 1 gathered carer ratings on the
existing domains and facets of the COMQOL-A5 (Cummins,
1997), a well-documented and validated tool for measuring QoL
with the general adult population. Study 2 utilized photovoice
methodology to capture carers experiences of living with HD.
Study 3 investigated the emerging themes from studies 1 and 2
in a focus group setting drawing on both carer and professional
perspectives. The HDQoL-C examines the caregiving experience
of family carers and/or partners of patients living with HD. It is
a multidimensional, disease-specific, and subjective HR-QoL tool
that incorporates the individual’s physical health, psychological
state, level of independence, social relationships, and personal
beliefs. The original pilot version of the HDQoL-C contained
63 items for exploration that were reduced to 34 via psychometric
analysis. Participants respond to statements on a 10-point Likert
scale to indicate the extent to which they agree with the statement.
Cronbach’s alpha scores for the three components of the original
HDQoL-C scale demonstrate good internal consistency – 0.801
(practical aspects of caregiving), 0.844 (satisfaction with life), and
0.885 (feelings about living with HD), with test re–test reliability
for the same components being 0.86, 0.90, and 0.92, respectively
(Aubeeluck and Buchanan, 2007).
In this current study, all 63 original items were put forward to
the European HDQoL Working Group and these were discussed
for relevance to a European population and further additions
to the scale were made. The European HDQoL Working Group
carer questionnaire, a 47-item modified version of the HDQoL-C
was distributed for use in the Enroll clinical database.
The English questionnaire originating from the United
Kingdom was translated into all other languages using an EN
15038-certified translation process involving dual forward
translation including reconciliation and back translation.
Translations were made by members of the QoL working group
with a background in HD care who were proficient users of
English (Common European Framework of Reference – Level C1
or C2) and native speakers in the goal language. Different United
Kingdom-English, US-English, Australian-English, Canadian-
English versions, and Spanish–Spanish and US–Spanish versions
were translated to reflect specific regional and cultural differences
within a particular language where appropriate.
Analytic Strategy
For the purposes of the analysis, the sample of 1716
partners/carers was randomly allocated to two equal groups
(Ns = 858): the first for the exploratory analyses and the second
for the confirmatory analyses.
Due to there being minimal psychometric testing on the
expanded HDQoL-C a standard psychometric process was
applied to the data. First, items were screened for normality
and item-total correlations to determine the extent to which
individual items correlated with the total score on the scale
were completed for both sections of the scale. Exploratory factor
analyses (EFAs) were conducted for each section to identify
subscales measuring different aspects of QoL. The resulting sub-
scales were then tested for reliability using Cronbach’s alpha.
The items on from the expanded HDQoL-C scale were treated
as the item pool from which to develop a refined shorter version
of the scale for ease of use in future clinical practice and research.
The psychometric process outlined above was repeated to develop
the short form (HDQoL-Cs) of the tool except more stringent
criteria were applied to remove items that did not correlate
with the total, or violated assumptions of normality. Nunnally
and Bernstein’s (1994) criteria for item-total correlations were
applied to remove items. Comrey and Lee’s (1992) minimum
threshold for factor loadings of 0.45 and maximum factor cross-
loadings of 0.3 were set and iterative EFAs were completed to
remove items that did not meet these standard psychometric
threshold criteria.
The final factor structures of the HDQoL-C and HDQoL-Cs
were then tested in confirmatory analysis to determine whether
these structures were a good fit for these data.
RESULTS
Exploratory Factor Analysis
In order to test the efficacy of the scale as currently used to
assess HD carers’ QoL in clinics across the world all items were
retained in the first EFA. Item total correlations were calculated
for both sections.
Section 1
In Section 1, no items had an item-total correlation of r < 0.3 so
all items met the criteria set by Nunnally and Bernstein (1994).
However, Section 2 had three items that did not meet this criteria
and could be candidates for exclusion: “I feel that Huntington’s
Disease brought something positive to my life” (r = 0.186), “I feel
that my own needs are important to others” (r = 0.276), and “I
feel that Huntington’s Disease has made me a stronger person”
(r = 0.178). These items were retained in the present analysis
to explore and confirm the factor structure in the currently
utilized clinical tool.
Exploration of univariate descriptive statistics for candidate
items revealed evidence of outliers and skew and kurtosis for
some variables; therefore, PAF with a direct oblimin rotation were
used for factor extraction. Separate PAF analyses were completed
to explore each section of the scale – Section 1 was concerned
with carer’s life satisfaction and Section 2 was concerned with
carer’s feelings about themselves and others.
The Kaiser–Meyer–Olkin (KMO) measure of sampling
adequacy showed the data for Section 1 to be factorable
(KMO = 0.856), Bartlett’s test of sphericity was also highly
significant (χ2 = 2868, df = 36, p < 0.001). Low off-diagonal
values in the anti-image correlation matrix also indicated that
the data were suitable for factor analysis (Tabachnick and Fidell,
2007). Eigen values and the Scree plot both indicated a two
factor solution with six items loading on to Factor 1 and three
items loading on to Factor 2. No problematic cross-loadings were
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identified (cross-loadings>0.2 are reported in the pattern matrix
in Table 1).
Section 2
For Section 2, the KMO measure of sampling adequacy showed
the data to be factorable (KMO = 0.926), Bartlett’s test of
sphericity was also highly significant (χ2 = 14,339, df = 703,
p < 0.001). Low off-diagonal values in the anti-image correlation
matrix also indicated that the data were suitable for factor
analysis (Tabachnick and Fidell, 2007). Initial analysis suggested
eight factors with Eigen values greater than one. The pattern
matrix showed many items with cross loadings and Factor
loadings below the minimum 0.32 specified by Tabachnick
and Fidell (2007) suggesting a problematic factor structure.
Costello and Osborne (2005) described the Eigen values >1
criteria as a highly inaccurate rule of thumb. We therefore
used the Scree plot to identify three factors, the PAF analysis
was then re-run with this number of factors which produced
a more parsimonious factor structure. The pattern matrix for
this analysis is shown in Table 2. There were 14 items in Factor
1, 13 in Factor 2, and 10 in Factor 3. Some items showed
cross-loadings >0.3 and some factor loadings did not meet the
minimum criteria for inclusion. Nonetheless, reliability analyses
showed that the factors were internally consistent: all Cronbach’s
alphas were >0.8.
These analyses show that while the scale meets
some threshold standards, there are a number of sub-
optimal items included that undermine the psychometric
properties of the scale.
In the next section, we describe the application of more
stringent psychometric criteria and detail the item reduction
procedure by which items were excluded, first through violations
of normality, then item-total correlations, and finally by
excluding all items that did not meet Comrey and Lee’s (1992)
“fair” criteria: minimum threshold for factor loadings of 0.45 and
maximum factor cross-loadings of 0.3. This approach resulted in
a shortened version of the scale.
TABLE 1 | Pattern matrix for Section 1 – satisfaction with life.
Retained items Factor 1 Factor 2
How satisfied are you with feeling a part of your social
environment?
0.879 –
How satisfied are you with your relationships with your
friends?
0.742 –
How satisfied are you with your psychological health? 0.687 –
How satisfied are you with what you have achieved in
life?
0.646 –
How satisfied are you with family relationships? 0.586 –
How satisfied are you with your physical health? 0.570 –
How satisfied are you with the professional support you
receive?
– 0.815
How satisfied are you with the medical treatment that
your HD relative(s) receive(s)?
– 0.811
How satisfied are you with the way other people behave
toward the HD person?
0.264 0.344
Bold font denotes the factors that items load on to most strongly.
TABLE 2 | Pattern matrix for Section 2 – feelings about living with HD.
Retained items Factor 1 Factor 2 Factor 3
I feel sad 0.848 – –
I feel depressed 0.805 – –
I feel a sense of grieving 0.754 – –
I feel a sense of loss 0.715 – –
I feel stressed 0.694 – –
I feel exhausted 0.682 – –
I feel a sense of anguish 0.673 – –
I feel full of fear 0.573 – –
I feel lonely 0.459 0.218 0.211
I feel guilty 0.445 –
I feel isolated 0.425 – 0.235
I feel financially disadvantaged 0.385 – –
I feel I get enough sleep 0.348 0.254 –
I feel worried about the genetic
consequences of HD
0.265 – –
I feel that HD has made me a stronger
person
0.625
I feel supported – 0.619 –
I feel that my role as a carer is rewarding – 0.615 –
I feel satisfied with my overall QoL 0.332 0.577 –
I feel that I can cope 0.207 0.577 –
I feel there is hope for the future 0.230 0.547 –
I feel comforted by my beliefs (religious,
philosophical, or spiritual)
– 0.518 –
I feel I have somebody to turn to for
assistance if I am overwhelmed
– 0.484 –
I feel happy 0.397 0.484 –
I feel that HD brought something positive to
my life
– 0.459 –
I feel safe 0.265 0.449 –
I feel that my own needs are important to
others
0.344 –
I feel I have enough time for myself 0.237 0.332 –
I feel embarrassed by the behavior of my
HD relative(s)
– – 0.819
I feel ashamed of the behavior of my HD
relative(s)
– – 0.781
I feel restricted by having to provide
continuous care
– – 0.497
I feel restricted by the need to maintain
secrecy about HD in the family
– – 0.493
I feel resentful 0.228 – 0.489
I feel threatened – 0.454
I feel restricted by a regimented daily routine 0.226 – 0.429
I feel that I have had a duty of care forced
on me
– 0.404
I feel frustrated by the discrimination of
others toward my HD relative(s)
0.219 –0.215 0.395
I feel frustrated by the misconceptions of
others toward my HD relative(s)
0.275 –0.218 0.378
I feel like I don’t know who I am anymore 0.350 0.354
Bold font denotes the factors that items load on to most strongly.
Short Version HDQoL-Cs
The HDQoL-C is currently in use both in clinical settings and for
research purposes; however, the preceding analysis demonstrated
that the scale has some sub-optimal psychometric properties.
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The following section details the process of refining the items
through a standard psychometric process to produce a shorter
more reliable version of the scale.
Scrutiny of items for assumptions of normality revealed that
the item “I feel threatened” was highly skewed and kurtosed
as very few participants indicated that they felt threatened
(67% answered with the lowest possible level of threat on the
10-point Likert scale and only 6.7% reporting a level of threat
higher than the mid-point on the scale), as a result this item was
removed. Item-total correlations were conducted and found three
problematic items with r < 0.3, these items were removed and
all item-total correlations then met the threshold for inclusion in
the PAF analysis.
Section 1
For section 1, the KMO measure of sampling adequacy showed
the data to be factorable (KMO = 0.838) and Bartlett’s test
of sphericity was also highly significant (χ2 = 2653, df = 28,
p < 0.001). PAF analysis revealed two factors with one item in
Factor 2 (How satisfied are you with the way other people behave
toward the HD person) not meeting the criteria of Factor loadings
>0.45 with no cross loadings >0.3. Thus, Section 1 retained
all but one item for the shortened version of the questionnaire.
See Table 3 for the factor structure.
Section 2
For Section 2, the KMO measure of sampling adequacy again
showed the data to be factorable (KMO = 0.927) and Bartlett’s
test of sphericity was also highly significant (χ2 = 13,427,
df = 595, p < 0.001). Initial analysis suggested six factors
with Eigen values >1. As with the first analysis, however, we
used the Scree plot to identify a three-factor solution and the
PAF analysis was re-run specifying these factors. The pattern
matrix again showed items with cross-loadings >0.3 and some
factor loadings did not meet the minimum criteria for inclusion.
The recommended criterion value of 0.45 was then applied
to the factor loadings and all items that did not meet this
threshold were excluded. Items with cross-loadings of >0.3
were also removed. Fourteen items were removed in the first
EFA. This approach was repeated until all remaining items
TABLE 3 | Pattern matrix for satisfaction with life – short form.
Retained items Factor 1 Factor 2
How satisfied are you with feeling a part of your social
environment?
0.866 –
How satisfied are you with your relationships with your
friends?
0.747 –
How satisfied are you with your psychological health? 0.689 –
How satisfied are you with what you have achieved
in life?
0.655 –
How satisfied are you with family relationships? 0.591 –
How satisfied are you with your physical health? 0.577 –
How satisfied are you with the professional support you
receive?
– 0.829
How satisfied are you with the medical treatment that
your HD relative(s) receive(s)?
– 0.766
Bold font denotes the factors that items load on to most strongly.
in the final iteration met these criteria. The PAF analysis for
the final set of items is reported below. See Table 4 for the
factor structure.
The final model showed strong sampling adequacy
(KMO = 0.885) and Bartlett’s test of sphericity was also
highly significant (χ2 = 6672, df = 136, p < 0.001). Factor 1
included eight items and was indicative of negative emotions
such as grieving, loss, stress, and exhaustion. Factor 2 included
seven items and was more positively framed, with items
focused on life satisfaction, the rewarding aspects of caring,
coping, and hope for the future. Factor 3 only had two items
but these were both robust (factor loadings > 0.8) and were
focused on shame and embarrassment about the behavior of
the HD relative. Reliability tests found Cronbach’s alpha = 0.900
for Factor 1, Cronbach’s alpha = 0.807 for Factor 2, and
Cronbach’s alpha = 0.863 for Factor 3, with no candidate
items for removal in any factor. The short form of the tool
was named HDQoL-Cs.
Confirmatory Factor Analysis
Missing data were handled using the data imputation method
predictive mean matching (PPM), using the Mice package in
R. CFA was conducted on the HDQoL-C and HDQoL-Cs.
Proposed models of the factor structures shown by the PAF
analysis were tested: For the HDQoL-C Model 1 tested Section
1, “Satisfaction with life” from the full version of the HDQoL-
C. The factor structure that was tested had nine items and
two factors. Model 2 tested Section 2, “Feelings about living
with HD” from the full version of the HDQoL-C which had 38
items and 3 factors.
TABLE 4 | Pattern matrix for feelings about living with HD – short form.
Retained items Factor 1 Factor 2 Factor 3
I feel sad 0.830 – –
I feel depressed 0.769 – –
I feel a sense of grieving 0.741 – –
I feel a sense of loss 0.722 – –
I feel exhausted 0.692 – –
I feel stressed 0.692 – –
I feel a sense of anguish 0.662 – –
I feel full of fear 0.551 – –
I feel that I can cope – 0.668 –
I feel there is hope for the future – 0.614 –
I feel satisfied with my overall QoL 0.273 0.598 –
I feel supported – 0.589 –
I feel comforted by my beliefs (religious,
philosophical, or spiritual)
– 0.588 –
I feel that my role as a carer is rewarding – 0.578 –
I feel safe – 0.524 –
∗ I feel ashamed of the behavior of my
HD relative(s)
– – 0.894
∗ I feel embarrassed by the behavior of
my HD relative(s)
– – 0.861
∗Excluded from final version of feelings about living with HD – short form due
to CFA outcomes. Bold font denotes the factors that items load on to most strongly.
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The factor structure for the HDQoL-Cs was also tested
with Model 3 testing the shortened version of “Satisfaction
with life.” Model 4 tested the shortened version of “Feelings
about living with HD” which had 17 items and 3 factors.
Sampling adequacy was “marvelous” (Hutcheson and Sofroniou,
1999; Field, 2013) according to the KMO measure for all
models (Table 5). Bartlett’s test of sphericity was highly
significant (Table 5) indicating the correlation matrix is
factorable. The sample size was >200 (N = 858) and more
than adequate for a CFA (Worthington and Whittaker, 2006).
Therefore, the maximum-likelihood method was employed and
the first variable in each subscale was set as one for data
scaling purposes.
There were no negative error variances (Heywood Cases)
in Models 1 (“Satisfaction with life”), 2 (“Feelings about living
with HD”), or 3 (“Satisfaction with life” short), and none of
the squared multiple correlations (SMCs) exceeded 1. Factor
loadings were examined for each model; for Model 1 the lowest
loading was the item “How satisfied are you with the way
other people behave toward the HD person?” (r2 = 0.33).
The item reduction process for the shortened form removed
the weakest item from Model 3 (“Satisfaction with life” –
short) and the revised model fit is reported in Table 5. The
weakest item in Model 2 was “I feel that HD has made
me a stronger person” (r2 = 0.09). The EFA for Model 2
included a substantial number of problematic items that were
removed in creating HDQoL-Cs, Model 4 tests the resultant
factor structure.
Model 4 (“Feelings about living with HD” – short) could
not be computed due to the presence of an extreme Heywood
case in Factor 3. Given that this was a two-item factor (which
can be considered psychometrically problematic in itself) the
analysis was re-run on a two factor solution with 15 items –
excluding “I feel ashamed of the behavior of my HD relative(s)”
and “I feel embarrassed by the behavior of my HD relative(s)” in
order to render the model computable. Thus, the fit measures in
Table 5 are for a two-factor solution to the “Feelings about living
with HD” section.
Initial CFAs showed all of the fit indices were beyond the
recommended thresholds with values indicating that the models
were a mediocre fit for the data. However, covariates were
identified in each model and the confirmatory models were
adjusted to include covariance between items. A number of
measures of fit were examined for the re-specified models
(Table 5) taken from various types of fit indices including:
overall fit (Chi-square), absolute fit (SRMR and RMSEA),
and incremental fit (NFI, CFI, and TLI). Chi-square fit tests
were significant although the sample size makes this highly
likely even when the data fit the model well. Models 1 and
2 showed a much improved fit, with most other estimates
within acceptable levels. Models 3 and 4 showed a good
fit with all thresholds criteria being met except for RMSEA
for Model 3. The HDQoL-Cs showed improved levels of fit
compared to the HDQoL-C with most fit statistics showing
improvements for the shortened version over the original full-
length version.
Inferential Analyses – Validation
Inferential tests were conducted to examine differences in
reported QoL for carers with differing personal circumstances
using the HDQoL-Cs as an outcome variable. Due to uneven
sample sizes and outliers in all analyses non-parametric tests
of difference were employed throughout. In each analysis,
the total score for Section 1 and Section 2 was compared
between groups. To control for the number of comparisons,
the threshold alpha level for significance was set to 0.01.
For each validation test, we first compared groups across
the overall scales (satisfaction with life and feelings about
living with HD). Where differences were found for the overall
scores these were followed up to examine differences on the
relevant sub-scales.
Spousal carers were compared with all other categories of carer
using Mann–Whitney U-tests and no difference was found for
overall satisfaction with life Z = −0.493 (N1 = 520, N2 = 1123),
p = 0.622. However, significant differences were shown for
total score for feelings about living with HD Z = −2.729
(N1 = 509, N2 = 1093), p = 0.006 (spousal carers: median = 110,
IQR = 42.0; other carers: median = 114, IQR = 43.0). Analyses
of the subscales showed that Subscale 1 was not significant
(p = 0.657); however, Subscale 2 showed a significant contrast
Z = −2.729 (N1 = 519, N2 = 1109), p < 0.001 such that
carers who looked after their spouse/partner had reduced
average sense of coping, hope for the future, and overall
QoL (spousal carers: median = 44, IQR = 20; other carers:
median = 48, IQR = 18).
These analyses were then repeated for carers whose parent was
the HD patient. Mann–Whitney U-tests found no difference for
overall satisfaction with life Z = −0.499 (N1 = 175, N2 = 1468),
p = 0.618. However, significant differences were shown for
total score for feelings about living with HD Z = −3.087
(N1 = 176, N2 = 1426), p = 0.002 (carers for parents:
median = 116.3, IQR = 41.0; other carers: median = 109.96,
IQR = 42.0). Analyses of the subscales showed that for this
group it was Subscale 1 (carers for parents: median = 53.14,
TABLE 5 | Model fit for HDQoL-C and HDQoL-Cs.
Models χ2 df p RMSEA SRMR CFI TLI NFI KMO Bartlett’s test
1. Satisfaction 119.215 22 <0.001 0.071 0.045 0.971 0.955 0.965 0.866 χ2(36) = 3144.50, p < 0.001
2. Feelings 2329.95 655 <0.001 0.056 0.060 0.873 0.864 0.832 0.926 χ2(595)X = 11,843, p < 0.001
3. Satisfaction (short) 85.013 16 <0.001 0.072 0.033 0.977 0.960 0.972 0.850 χ2(28) = 2871.1, p < 0.001
4. Feelings (short) 193.069 84 <0.001 0.040 0.036 0.980 0.975 0.966 0.892 χ2(136) = 5913, p < 0.001
Cut-off values (Hu and Bentler, 1999) N/A N/A >0.05 <=0.06 <=0.08 >=0.95 >=0.95 >=0.95
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IQR = 28.0; other carers: median = 48.12, IQR = 28.0) that was
significantly different to other carer groups Z = 3.180 (N1 = 178,
N2 = 1496), p = 0.001; however, Subscales 2 (p = 0.165) and 3
(p = 0.882) did not differ significantly. This indicated that carers
of parents experienced lower scores for negative emotions and
experiences of grieving, loss, and exhaustion when compared
to other groups.
Carers for their children showed a different pattern to
carers for parents in that significant differences were shown
in total feelings score Z = −3.995 (N1 = 201, N2 = 1401),
p < 0.001 (carers for children: median = 103.35, IQR = 43.0;
other carers: median = 111.72, IQR = 40.0). Analyses of the
subscales also showed differences for Subscale 1, Z = 6.260
(N1 = 206, N2 = 1468), p < 0.001 (carers for children:
median = 41.31, IQR = 26.0; other carers: median = 49.72,
IQR = 27.0); however, Subscales 2 (p = 0.687) and 3
(p = 0.695) did not differ significantly. The differences in
life satisfaction did not pass the 0.01 threshold set for
significance, but were the largest observed in these analyses,
Z = 2.02 (N1 = 205, N2 = 1438), p = 0.036 (carers
for children: median = 59.79, IQR = 20; other carers:
median = 61.83, IQR = 16.0). These difference would indicate
that carers who are caring for their children have more negative
emotional experiences.
Carers who lived with the HD patient were compared
with those who did not using Mann–Whitney U-tests and
no difference was found for satisfaction with life Z = −1.572
(N1 = 346, N2 = 1294), p = 0.116. However, significant
differences were again shown for measures of feelings about
living with HD Z = −4.504 (N1 = 339, N2 = 1260), p < 0.001.
(living with HD patient: median = 109, IQR = 43.0; not
living with HD patient: median = 116, IQR = 39.0). Analyses
of the subscales showed that all were significantly different
between those who cared for and lived with the HD patient
Subscale 1 (p = 0.006, living with HD patient: median = 49.0,
IQR = 28.75; not living with HD patient: median = 54,
IQR = 25.0) and Subscale 2 (p < 0.001, living with HD
patient: median = 45, IQR = 20.0; not living with HD patient:
median = 48, IQR = 18.0).
Comparisons were made between carers who had children
who were at risk, carried the gene, or were symptomatic. No
difference was found for satisfaction with life Z = −0.059
(N1 = 655, N2 = 977), p = 0.953. However, significant differences
were again shown for measures of feelings about living with
HD Z = −4.514 (N1 = 635, N2 = 956), p < 0.001 (children who
are at risk/carrier/symptomatic: median = 108, IQR = 43.0; no
children who are at risk/carrier/symptomatic: median = 117,
IQR = 42.0). Analyses of the subscales showed that feelings
Subscale 1 (p < 0.001) were significantly worse for carers with
children who were at risk, carried the gene, or were symptomatic
(children who are at risk/carrier/symptomatic: median = 47.0,
IQR = 28.0; no children who are at risk/carrier/symptomatic:
median = 54.0, IQR = 26.0). There was no difference for
Subscale 2 (p = 0.098).
Weak, negative correlations were found between duration in
the caring role and total score for life satisfaction (rs = −0.066,
N = 1563, p = 0.009) and feelings about living with HD
(rs = −0.072, N = 1602, p = 0.005). Two sub-scales were
significantly correlated with duration in the caring role. Feelings
Subscale 1 (rs = −0.132, N = 1583, p < 0.001) and satisfaction
Subscale 1 (rs = −0.076, N = 1609, p = 0.002). All other
subscales p > 0.2.
DISCUSSION
The present study allowed for the examination and refinement
of a clinical tool to measure the QoL of carers of individual’s
living with HD. This was conducted as part of an international
study of the largest sample of HD carers/partners that has been
possible to date and resulted in a psychometrically robust tool
to measure the QoL experienced by these individuals. Based
on the present study, the HDQoL-C and HDQoL-Cs can be
considered the definitive measures of carer/partner QoL and
can be utilized in any such population across the world. The
validation process will go some way to address the concerns
from Mestre et al. (2018) in their call for further validation of
QoL measures for HD patients and their carers. Full versions
of HDQoL-C and HDQoL-Cs and the scoring methods can be
found in the Appendix.
The analyses showed that the HDQoL-C was satisfactory
with regards to most standards in EEFs. Section 1,
“Satisfaction with life” identified two factors (satisfaction
with self and personal relationships and satisfaction
with the behavior of health professionals and others)
and was considerable more robust than Section 2,
“Feelings about living with HD.” Section 2 included
three factors (negative emotions such as sadness and
loss, positive emotions such as hope for the future and
coping and thirdly shame and embarrassment), but these
included items that did not meet standard psychometric
thresholds in scale development (see e.g., Comrey and Lee, 1992;
Tabachnick and Fidell, 2007).
Based on these outcomes a short version of the scale was
developed and tested to determine whether the psychometric
properties could be improved and whether a more efficient
and convenient tool could be produced. Section 1 remained
largely intact, with only one item failing to meet the threshold
requirements. However, Section 2 was substantially reduced
in length once items that were problematic in terms of non-
normality, item-total correlations, weak factor loadings, and
high cross loadings were removed. This resulted in a 23-item
short form of the HDQoL-C (HDQoL-Cs) which also had
improved psychometric properties. The short form continued
to have two factors in Section 1 and three factors in Section 2.
The expanded version of the HDQoL-C differs from the 2007
and 2013 remodeling, in that although “Satisfaction with life”
and “Feelings about living with HD” are retained, “Practical
aspects of caregiving,” a factor established in previous versions
is now situated within “Satisfaction with life.” This might
suggest that while the practicalities of caregiving are important
to this population (see also Rothing et al., 2015), satisfaction
and feelings in a carer/partner role take precedence over
such practicalities.
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Confirmatory factor analysis suggested a good fit with the
data, although it also indicated that the three factor solution
to the shortened “Feelings about living with HD” scale was
not computable and may be best presented with two subscales
rather than three. There was evidence that items covaried with
strong correlations between, for example items asking about
grieving and loss. The was also a strong relationship observed
between satisfaction with psychological health and satisfaction
with friendships which emphasizes the importance of social
support for good mental health outcomes among carers and
warrants further research in the future.
The good fit and positive psychometric outcomes observed
were in spite of the diversity of the population tested when
compared with the United Kingdom population recruited in
the original development of the HDQoL-C. Aubeeluck et al.
(2013) showed that there were differing factor loadings from the
United Kingdom sample in a French and Italian sample. The
factor structure in the present study, however, differed from both
the original and shortened French/Italian version and cultural
differences in the populations involved may have impacted on
the factor structure and model fit. As such, the expanded version
of the HDQoL-C and HDQoL-Cs may not fully capture the
nuanced variation in factor structure across cultures. The present
data set did not offer the opportunity to make such cross-
cultural or language comparisons which could be considered a
limitation of the study. There is, however, clearly a benefit to
having a generalized international tool that allows cross-cultural
comparisons of standards of QoL between HD partners/carers
in different locations. A standard international measure will
facilitate these comparisons, and it remains that further studies
to unpack cultural differences in experiencing life as an HD
carer are required.
Analysis utilizing the short-form of the questionnaire to
examine differences based on demographic and individual
circumstances demonstrated that the burden of caregiving was,
on average, greater for spouses and partners than for other
family members. Caregiving impacted on feelings to a greater
extent for those living with the HD patient. Carers who had
children who either had the potential to develop HD, carried
the gene or were symptomatic had lower scores for Section
2 of the scale, indicating a greater sense of loss and sadness.
Such data indicate that these groups would benefit from greater
emotional and psychological support and further the argument
for psychological interventions as standard for partners and/or
carers of individual’s living with HD.
While many of the items on the scale are not explicitly HD
specific, it is important to note the implicit complexity of latent
variables and the ability of these to measure their impact on
the HD carers QoL. Through the qualitative exploration of what
matters for HD carers in terms of their life quality, we know
that the impact of caregiving in HD has a variety of unique
and distinct features that set it apart from other types of family
caregiving. For example, the genetic nature of HD means that
it is not unusual for children to care for their parents before
presenting with symptoms themselves or for parents to care for
a spouse and then a child over a number of generations. Such a
chronic and extended caregiving role can exacerbate the isolation,
sense of loss for their family members and their own future,
feelings of guilt, anger, burden, and disempowerment for HD
families (Aubeeluck et al., 2012). Therefore, while for example,
“genetic issues” are not explicit within the scale, the impact of
these in terms of “sense of loss” is clear. These genetic issues are
further evidenced by the increased negative feelings experienced
by parents caring for their children.
In summary, the present study has demonstrated that the
clinical tool devised to measure QoL in HD partners/carers
has a good factor structure and showed merit in distinguishing
different groups of HD carers in terms of their lived experience.
The development of the short form of the questionnaire showed
a slightly more reliable factor structure, but more importantly
reduced the burden of completing the instrument by reducing the
questions to be completed from 46 to 23, which is an important
consideration for a group with challenging life circumstances.
The measures validated here will facilitate the examination of the
complex issues that impact upon HD carers (e.g., Domaradzki,
2016) and are already of use in clinical practice and research
internationally. We therefore recommend the use of the HDQoL-
Cs as a measure of self-reported QoL in carers of individual’s
living with HD, but note that the expanded version has adequate
psychometric properties for continued use. The HDQoL-Cs can
help clinicians to understand and support carers in their role,
facilitate carers engaging in self-reflection, and encourage the
investigation of novel research questions. We therefore argue that
HDQoL-Cs should be considered the definitive measure of HD
carer QoL for researchers and clinicians due to its improved ease
of use and psychometric properties. This international validation
further supports international and cross-cultural comparisons
of QoL using a common metric which has not previously
been possible. These psychometrically validated tools can aid
and guide the implementation of therapeutic interventions to
improve life quality in this population.
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APPENDIX
HDQoL-C
Please respond to each question – check the box that best reflects your opinions.
10 9 8 7 6 5 4 3 2 1
(Strongly
agree)
(Strongly
disagree)
Section 1
1. How satisfied are you with feeling a part of your social environment?
2. How satisfied are you with your relationships with your friends?
3. How satisfied are you with your psychological health?
4. How satisfied are you with what you have achieved in life?
5. How satisfied are you with family relationships?
6. How satisfied are you with your physical health?
7. How satisfied are you with the professional support you receive?
8. How satisfied are you with the medical treatment that your HD relative(s) receive(s)?
9. How satisfied are you with the way other people behave toward the HD person?
Section 2
1r. I feel sad
2r. I feel depressed
3r. I feel a sense of grieving
4r. I feel a sense of loss
5r. I feel stressed
6r. I feel exhausted
7r. I feel a sense of anguish
8r. I feel full of fear
9r. I feel lonely
10r. I feel guilty
11r. I feel isolated
12r. I feel financially disadvantaged
13. I feel I get enough sleep
14r. I feel worried about the genetic consequences of HD
15. I feel that HD has made me a stronger person
16. I feel supported
17. I feel that my role as a carer is rewarding
18. I feel satisfied with my overall QoL
19. I feel that I can cope
20. I feel there is hope for the future
21. I feel comforted by my beliefs (religious, philosophical, or spiritual)
22. I feel I have somebody to turn to for assistance if I am overwhelmed
23. I feel happy
24. I feel that HD brought something positive to my life.
25. I feel safe.
26. I feel that my own needs are important to others.
27. I feel I have enough time for myself.
28r. I feel embarrassed by the behavior of my HD relative(s).
29r. I feel ashamed of the behavior of my HD relative(s).
30r. I feel restricted by having to provide continuous care.
31r. I feel restricted by the need to maintain secrecy about HD in the family.
32r. I feel resentful.
33r. I feel threatened.
34r. I feel restricted by a regimented daily routine.
35r. I feel that I have had a duty of care forced on me.
36r. I feel frustrated by the discrimination of others toward my HD relative(s).
37r. I feel frustrated by the misconceptions of others toward my HD relative(s).
38r. I feel like I don’t know who I am anymore.
Scoring Key. Section 1. Satisfaction with life. Factor 1. Sum Questions 1–6 and calculate the mean. Factor 2. Sum Questions 7–9 and calculate the mean. Section 2.
Feelings about living with HD. Factor 1. Sum Questions 1–14 and calculate the mean. Factor 2. Sum Questions 15–27 and calculate the mean. Factor 3. Sum Questions
28–36 and calculate the mean. Items with an r are reverse coded such that a score of 10 = 1, 9 = 2, 8 = 3, . . ., 1 = 10.
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HDQoL-Cs
Please respond to each question – check the box that best reflects your opinions.
10 9 8 7 6 5 4 3 2 1
Strongly
agree
Strongly
disagree
Section 1
1. How satisfied are you with feeling a part of your social environment?
2. How satisfied are you with your relationships with your friends?
3. How satisfied are you with your psychological health?
4. How satisfied are you with what you have achieved in life?
5. How satisfied are you with family relationships?
6. How satisfied are you with your physical health?
7. How satisfied are you with the professional support you receive?
8. How satisfied are you with the medical treatment that your HD relative(s) receive(s)?
Section 2
1r. I feel sad
2r. I feel depressed
3r. I feel a sense of grieving
4r. I feel a sense of loss
5r. I feel exhausted
6r. I feel stressed
7r. I feel a sense of anguish
8r. I feel full of fear
9. I feel that I can cope
10. I feel there is hope for the future
11. I feel satisfied with my overall QoL
12. I feel supported
13. I feel comforted by my beliefs (religious, philosophical, or spiritual)
14. I feel that my role as a carer is rewarding
15. I feel safe
Scoring Key. Section 1. Satisfaction with life. Factor 1. Sum Questions 1–8 and calculate the mean. Section 2. Feelings about living with HD. Factor 1. Sum Questions 1–8
and calculate the mean. Factor 2. Sum Questions 9–15 and calculate the mean. Items with an r are reverse coded such that a score of 10 = 1, 9 = 2, 8 = 3, . . ., 1 = 10.
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